# WDI-20 Phase 1 engineering acceptance report

**Status:** Phase 1 engineering vertical slice implemented; clinical deployment remains blocked.  
**Environment:** local development, synthetic records only.  
**Date:** 2026-10-24.

## Delivered

- Shared Phase-1 pack registry for diabetes, hypertension, and chronic kidney disease.
- Typed clinical-assessment API: `POST /v1/disease-intelligence/clinical-assess`.
- Unit normalization for glucose, weight, creatinine, and UACR-compatible values.
- Longitudinal evidence references and deterministic input hashes.
- Missing-data, BP-pair, albuminuria-gap, and stale-measurement findings.
- Fail-closed behavior for an unavailable disease pack.
- Draft care plans that explicitly require clinician approval and block diagnosis, prescribing, treatment changes, referrals, and record writes.
- Synthetic fixture containing 60 scenarios: 20 for each Phase-1 disease.

## Verification

- `58 passed` local API tests.
- Phase-1 evaluation: `PASS`, 60 synthetic cases, 20 per disease.
- WDI structural gate: `IN_PROGRESS`, all structural checks passing.
- Synthetic WDI-20 E2E: `PASS`.

## Boundaries retained

The engine does not diagnose, calculate clinical risk, recommend treatment, prescribe, refer, write clinical records, or claim clinical accuracy. It does not train on unapproved data. Gemini and TRION remain behind deferred adapters; no endpoint or credential was invented. WyshCare remains unmodified.

## Remaining acceptance work

Independent clinical review, equation/version verification for any future risk calculators, representative evaluation data under approved terms, formal clinician adjudication, production security review, and external connectivity verification remain open. Therefore `WDI_PROGRAM_STATUS=IN_PROGRESS` is preserved.
